Work

Abstract LB-78: Pharmacogenomic analysis of a phase III trial of gemcitabine/axitinib versus gemcitabine/placebo in patients with advanced pancreatic cancer

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am10-lb-78

Authors: Katrina Loomis, Graham Brock, J. Andrew Williams, Feng Gao, Rebecca Fan, Alejandro Ricart, Dirk Richel, Jaafar Bennouna, Gregory M. Springett, Joan Maurel, Diether Lambrechts, Eric Van Cutsem

Institutions: Pfizer (United States), Amsterdam UMC Location University of Amsterdam, Moffitt Cancer Center, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Universitair Ziekenhuis Leuven

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2326566886

Cites:

Cited by:

Related to: 10